Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide ; day:21 ; month:4 ; year:2024 ; pages:1-10
Journal of thrombosis and thrombolysis ; (21.4.2024), 1-10
- Urheber
-
Sadowski, Marcin
Ząbczyk, Michał
Undas, Anetta
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11239-024-02980-5
- URN
-
urn:nbn:de:101:1-2407090843345.973068922350
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sadowski, Marcin
- Ząbczyk, Michał
- Undas, Anetta
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impaired fibrinolysis in critically ill COVID-19 patients
Impaired fibrinolysis in degenerative mitral and aortic valve stenosis
Measuring Fibrinolysis
Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia
Impaired Whole-Blood Fibrinolysis is a Predictor of Mortality in Intensive Care Patients
Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis
Fibrinolysis Inducing Compounds
Familial Primary Fibrinolysis
High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states
Anti-inflammatory HDL effects are impaired in atrial fibrillation
Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study
Blood coagulation, fibrinolysis and platelets
Impaired fibrinolysis in critically ill COVID-19 patients
Impaired fibrinolysis in degenerative mitral and aortic valve stenosis
Measuring Fibrinolysis
Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia
Impaired Whole-Blood Fibrinolysis is a Predictor of Mortality in Intensive Care Patients
Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis
Fibrinolysis Inducing Compounds
Familial Primary Fibrinolysis
High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states
Anti-inflammatory HDL effects are impaired in atrial fibrillation
Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study
Blood coagulation, fibrinolysis and platelets
Impaired fibrinolysis in critically ill COVID-19 patients
Impaired fibrinolysis in degenerative mitral and aortic valve stenosis
Measuring Fibrinolysis
Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia
Impaired Whole-Blood Fibrinolysis is a Predictor of Mortality in Intensive Care Patients
Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis
Fibrinolysis Inducing Compounds
Familial Primary Fibrinolysis
High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states
Anti-inflammatory HDL effects are impaired in atrial fibrillation
Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study